William C. Bayless Jr. - 09 Aug 2022 Form 4 Insider Report for AMERICAN CAMPUS COMMUNITIES INC

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Aug 2022, 16:43:59 UTC
Prior SEC filing
02 Jun 2022
Next SEC filing
07 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kim K. Voss, Attorney-in-fact

Key filing fact

William C. Bayless Jr. filed Form 4 for AMERICAN CAMPUS COMMUNITIES INC on 09 Aug 2022.

Key facts

  • This page summarizes William C. Bayless Jr.'s Form 4 filing for AMERICAN CAMPUS COMMUNITIES INC.
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 09 Aug 2022, 16:43.

Change

  • Previous filing in this sequence was filed on 02 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACC transaction

Common stock

Disposed to Issuer

Transaction value
Shares
-314,566
Change %
-100%
Price
Shares after
0
Date
09 Aug 2022
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACC transaction Derivative

Common Units of Limited Partnership Interest

Disposed to Issuer

Transaction value
$0
Shares
-52,500
Change %
-100%
Price
$0.000000*
Shares after
0
Date
09 Aug 2022
Ownership
Direct
Underlying class
Common Stock, par value $.01 per share
Underlying amount
52,500
Exercise price
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On August 9, 2022, pursuant to the Agreement and Plan of Merger, dated as of April 18, 2022 (as amended from time to time, the "Merger Agreement"), by and among Abacus Parent LLC, Abacus Merger Sub I LLC ("Merger Sub I"), Abacus Merger Sub II LLC ("Merger Sub II"), American Campus Communities, Inc. ("ACC") and American Campus Communities Operating Partnership LP (the "Partnership"), ACC merged with and into Merger Sub I (the "Company Merger"), each share of ACC common stock issued and outstanding immediately prior to the effective time of the Company Merger (other than shares held in ACC's deferred compensation plan) was automatically cancelled and converted into the right to receive an amount in cash equal to $65.47 per share, without interest.

Footnote F2

Includes 253,235 shares of unvested restricted stock. Pursuant to the Merger Agreement, each share of unvested restricted common stock granted pursuant to ACC's long-term incentive plans outstanding immediately prior to the effective time of the Company Merger automatically became fully vested and all restrictions and reacquisition rights thereon lapsed. All shares of ACC common stock represented thereby were considered outstanding for all purposes under the Merger Agreement and therefore automatically cancelled and converted into the right to receive an amount in cash equal to $65.47 per share, without interest.

Footnote F3

On August 9, 2022, pursuant to the Merger Agreement, Merger Sub II merged with and into the Partnership (the "Partnership Merger") and each limited partnership unit of the Partnership, or fraction thereof, that was issued and outstanding immediately prior to the effective time of the Partnership Merger held by the Reporting Person was automatically cancelled and converted into the right to receive an amount in cash equal to $65.47 per limited partnership unit, without interest.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .